Mass General Researcher Finds That Earlier Palliative Care Improves Patient Quality of Life in Serious Illnesses
Mass General clinician-researcher Jennifer Temel, MD, a Hostetter MGH Research Scholar, is studying the effects of palliative care on quality of life for patients with serious illnesses.
Bringing a 70-Year-Old Surgical Technique Into the 21st Century
Imagine your surprise if you needed heart surgery and were told your cardiac surgeon would be using the same technique their predecessors used in the 1940s.
MGH Research Scholars: The Power of Bold Giving and Big Ideas
The MGH Research Scholars program provides exceptional early- and mid-career investigators the funding they need to make transformative advances in their research.
Racing to Stop a ‘Silent’ Killer
The ability to detect ovarian cancer in its early stages continues to elude researchers. Cheng Wang, PhD, is determined to change that.
Breast Cancer Screening Research Highlights How Flawed Science Contributes to Health Disparities
Study highlights the pitfalls of basing clinical recommendations on data heavily skewed towards one race or ethnic group.
Five Things to Know About Bone Marrow and Stem Cell Harvest
A new method for harvesting bone marrow stem cells for transplant could be a game changer.
12 Days of Research at Mass General: A Strategy for Sneaking Drugs Into Tumor Cells
In the 12 days leading up to our holiday hiatus, we are looking back on the past year and sharing some highlights in Massachusetts General Hospital research news from each month of 2017.
12 Days of Research at Mass General: Aspirin and Risk of Cancer Death
In the 12 days leading up to our holiday hiatus, we are looking back on the past year and sharing some highlights in Massachusetts General Hospital research news from each month of 2017.
Researchers Use Machine Learning to Improve Breast Cancer Screening Techniques
Imagine enduring a painful, expensive and scar-inducing surgery—only to find out afterwards that it wasn’t necessary. This is the situation for many women with high-risk breast lesions.
Could the Microbiome be the Key to Ending Chemotherapy-Induced Pain?
Unfortunately, a third of cancer patients who receive chemotherapy encounter this as a side effect, a condition known as chemotherapy-induced peripheral neuropathy (CIPN). This neuropathy is a result of nerve damage or impairment of the nervous system and often is chronic.
- « Previous
- 1
- 2
- 3
- 4
- Next »